Bank Of America Corp Eliem Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.21 Trillion
- Q1 2025
A detailed history of Bank Of America Corp transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 37,287 shares of ELYM stock, worth $153,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,287
Previous 1,033,692
96.39%
Holding current value
$153,249
Previous $4.25 Million
96.4%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ELYM
# of Institutions
72Shares Held
51.5MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.68% of portfolio
-
Cantor Fitzgerald, L. P. New York, NY2MShares$8.22 Million0.18% of portfolio
-
Citigroup Inc1.85MShares$7.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$6.18 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.5MShares$6.17 Million0.69% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...